CATO 佳途CATO · CNAS + ANAB ISO 17034 双体系认可标准物质生产者CNAS + ANAB ISO 17034 dual-accredited reference material producer
销售顾问Sales contact 卢振明Kaka Lu+86 185 2048 1969kaka@cato-chem.com
Simvastatin

辛伐他汀 杂质对照品Simvastatin Impurities

EP53 个杂质条目53 impurity entries

本页汇总 辛伐他汀 的 53 个杂质对照品条目,其中药典杂质标注了 EP/USP 编号。杂质谱是仿制药杂质研究、方法开发与稳定性考察的起点——先锁定品种,再逐条比对结构差异与保留行为。This page collects 53 impurity reference standards of Simvastatin with EP/USP numbering where applicable. The impurity profile is the starting point for related-substance method development, forced degradation and stability studies.

批量索取报价 / COABulk quote / COA在全站目录中检索Search the full catalogue

相关研究文献Related literature

以下为 辛伐他汀(Simvastatin)在公开文献中的研究报道(题录信息,来源 PubMed),供方法开发与文献调研参考。Selected peer-reviewed publications on this drug substance — bibliographic records from PubMed.

  1. 杂质研究Impurity studiesGenotoxic and cytotoxic assessment of sitagliptin and simvastatin alone and in combination
    Pakistan journal of pharmaceutical sciences · 2021 · Majeed Khan H et al.  ·  PMID 34836863
  2. 杂质研究Impurity studiesThermal stability of simvastatin under different atmospheres
    Journal of pharmaceutical sciences · 2014 · Simões RG et al.  ·  PMID 24272683  ·  DOI
  3. 分析方法Analytical MethodsDevelopment and validation of a reversed-phase HPLC method for simultaneous analysis of butylhydroxyanisol, simvastatin and its impurities in tablet dosage forms
    Annales pharmaceutiques francaises · 2014 · El Karbane M et al.  ·  PMID 24997886  ·  DOI
  4. 分析方法Analytical MethodsAnalytical Method Development and Validation for Simultaneous Determination of Simvastatin and Mupirocin Using Reverse-Phase High-pressure Liquid Chromatographic Method
    Turkish journal of pharmaceutical sciences · 2021 · Kale R et al.  ·  PMID 34496550  ·  DOI
  5. 分析方法Analytical MethodsStability Indicating RP-HPLC Method for Simultaneous Determination of Simvastatin and Ezetimibe from Tablet Dosage Form
    Indian journal of pharmaceutical sciences · 2010 · Dixit RP et al.  ·  PMID 20838524  ·  DOI

辛伐他汀 —— 原料药与杂质对照品Simvastatin — drug substance & impurities

共 54 个条目(含原料药本体)54 items incl. the drug substance
Simvastatin structure
EP原料药 APIAPI
辛伐他汀Simvastatin
Simvastatin
CAS No.79902-63-9
Chemical FormulaC25H38O5
Purity>95%询价On request
10mg25mg50mg100mg
Simvastatin Impurity 1 Sodium Salt (Simvastatin EP Impurity A Sodium Salt) structure
EPA
辛伐他汀杂质1 钠盐 (辛伐他汀EP杂质A 钠盐)Simvastatin Impurity 1 Sodium Salt (Simvastatin EP Impurity A Sodium Salt)
Simvastatin Impurity 1 Sodium Salt (Simvastatin EP Impurity A Sodium Salt)
CAS No.101314-97-0
Chemical FormulaC25H39O6-·Na+
Purity>95%询价On request
10mg25mg50mg100mg
Simvastatin Impurity 1 Monomer (Simvastatin EP Impurity A) structure
EPA
辛伐他汀杂质1 单体 (辛伐他汀EP杂质A)Simvastatin Impurity 1 Monomer (Simvastatin EP Impurity A)
Simvastatin Impurity 1 Monomer (Simvastatin EP Impurity A)
CAS No.121009-77-6
Chemical FormulaC25H40O6
Purity>95%询价On request
10mg25mg50mg100mg
Simvastatin Impurity 1 Ammonium Salt(Simvastatin EP Impurity A Ammonium Salt) structure
EPA
辛伐他汀杂质1 铵盐(辛伐他汀EP杂质A 铵盐)Simvastatin Impurity 1 Ammonium Salt(Simvastatin EP Impurity A Ammonium Salt)
Simvastatin Impurity 1 Ammonium Salt(Simvastatin EP Impurity A Ammonium Salt)
CAS No.139893-43-9
Chemical FormulaC25H39O6-·NH4-
Purity>95%询价On request
10mg25mg50mg100mg
Simvastatin Impurity 2(Simvastatin EP Impurity B) structure
EPB
辛伐他汀杂质2(辛伐他汀EP杂质B)Simvastatin Impurity 2(Simvastatin EP Impurity B)
Simvastatin Impurity 2(Simvastatin EP Impurity B)
CAS No.145576-25-6
Chemical FormulaC27H40O6
Purity>95%询价On request
10mg25mg50mg100mg
Simvastatin Impurity 3(Simvastatin EP Impurity C) structure
EPC
辛伐他汀杂质3(辛伐他汀EP杂质C)Simvastatin Impurity 3(Simvastatin EP Impurity C)
Simvastatin Impurity 3(Simvastatin EP Impurity C)
CAS No.210980-68-0
Chemical FormulaC25H36O4
Purity>95%询价On request
10mg25mg50mg100mg
Simvastatin Impurity 4(Simvastatin EP Impurity D) structure
EPD
辛伐他汀杂质4(辛伐他汀EP杂质D)Simvastatin Impurity 4(Simvastatin EP Impurity D)
Simvastatin Impurity 4(Simvastatin EP Impurity D)
CAS No.476305-24-5
Chemical FormulaC50H76O10
Purity>95%询价On request
10mg25mg50mg100mg
Simvastatin Impurity 6(Simvastatin EP Impurity F) structure
EPF
辛伐他汀杂质6(辛伐他汀EP杂质F)Simvastatin Impurity 6(Simvastatin EP Impurity F)
Simvastatin Impurity 6(Simvastatin EP Impurity F)
CAS No.79952-44-6
Chemical FormulaC24H36O5
Purity>95%询价On request
10mg25mg50mg100mg
Simvastatin Impurity 7(Simvastatin EP Impurity G) structure
EPG
辛伐他汀杂质7(辛伐他汀EP杂质G)Simvastatin Impurity 7(Simvastatin EP Impurity G)
Simvastatin Impurity 7(Simvastatin EP Impurity G)
CAS No.1449248-72-9
Chemical FormulaC25H36O5
Purity>95%询价On request
10mg25mg50mg100mg
Simvastatin Impurity 25(Simvastatin EP Impurity I) structure
EPI
辛伐他汀杂质25(辛伐他汀EP杂质I)Simvastatin Impurity 25(Simvastatin EP Impurity I)
Simvastatin Impurity 25(Simvastatin EP Impurity I)
CAS No.79902-42-4
Chemical FormulaC23H34O5
Purity>95%询价On request
10mg25mg50mg100mg
Simvastatin Impurity 22(Simvastatin EP Impurity J) structure
EPJ
辛伐他汀杂质22(辛伐他汀EP杂质J)Simvastatin Impurity 22(Simvastatin EP Impurity J)
Simvastatin Impurity 22(Simvastatin EP Impurity J)
CAS No.864357-88-0
Chemical FormulaC26H40O5
Purity>95%询价On request
10mg25mg50mg100mg
Simvastatin Impurity 9 (Simvastatin EP Impurity M) structure
EPM
辛伐他汀杂质9 (辛伐他汀EP杂质M)Simvastatin Impurity 9 (Simvastatin EP Impurity M)
Simvastatin Impurity 9 (Simvastatin EP Impurity M)
CAS No.864357-87-9
Chemical FormulaC27H44O6
Purity>95%询价On request
10mg25mg50mg100mg
Simvastatin Impurity 6-d3(Simvastatin EP Impurity F-d3) structure
EPF-D3
辛伐他汀杂质6-d3(辛伐他汀EP杂质F-d3)Simvastatin Impurity 6-d3(Simvastatin EP Impurity F-d3)
Simvastatin Impurity 6-d3(Simvastatin EP Impurity F-d3)
CAS No.1330264-51-1
Chemical FormulaC24H33D3O5
Purity>95%询价On request
Simvastatin Impurity 8 structure
8
辛伐他汀杂质8Simvastatin Impurity 8
Simvastatin Impurity 8
CAS No.126313-98-2
Chemical FormulaC25H38O6
Purity>95%询价On request
10mg25mg50mg100mg
Simvastatin Impurity 11 structure
11
辛伐他汀杂质11Simvastatin Impurity 11
Simvastatin Impurity 11
CAS No.149949-01-9
Chemical FormulaC25H38O7
Purity>95%询价On request
10mg25mg50mg100mg
Simvastatin Impurity 12 structure
12
辛伐他汀杂质12Simvastatin Impurity 12
Simvastatin Impurity 12
CAS No.145576-26-7
Chemical FormulaC26H42O6
Purity>95%询价On request
10mg25mg50mg100mg
Simvastatin Impurity 13 structure
13
辛伐他汀杂质13Simvastatin Impurity 13
Simvastatin Impurity 13
CAS No.1092716-42-1
Chemical FormulaC25H38O7
Purity>95%询价On request
10mg25mg50mg100mg
Simvastatin Impurity 14 structure
14
辛伐他汀杂质14Simvastatin Impurity 14
Simvastatin Impurity 14
CAS No.1092716-44-3
Chemical FormulaC25H38O7
Purity>95%询价On request
10mg25mg50mg100mg
Simvastatin Impurity 15 structure
15
辛伐他汀杂质15Simvastatin Impurity 15
Simvastatin Impurity 15
CAS No.159143-77-8
Chemical FormulaC25H40O7
Purity>95%询价On request
10mg25mg50mg100mg
Simvastatin Impurity 16 structure
16
辛伐他汀杂质16Simvastatin Impurity 16
Simvastatin Impurity 16
CAS No.393825-04-2
Chemical FormulaC25H37NaO5
Purity>95%询价On request
10mg25mg50mg100mg
Simvastatin Impurity 17 structure
17
辛伐他汀杂质17Simvastatin Impurity 17
Simvastatin Impurity 17
CAS No.149949-05-3
Chemical FormulaC25H38O6
Purity>95%询价On request
10mg25mg50mg100mg
Simvastatin Impurity 18 structure
18
辛伐他汀杂质18Simvastatin Impurity 18
Simvastatin Impurity 18
CAS No.130468-11-0
Chemical FormulaC25H36O6
Purity>95%询价On request
10mg25mg50mg100mg
Simvastatin Impurity 19 structure
19
辛伐他汀杂质19Simvastatin Impurity 19
Simvastatin Impurity 19
CAS No.149949-02-0
Chemical FormulaC25H38O6
Purity>95%询价On request
10mg25mg50mg100mg
Simvastatin Impurity 23 structure
23
辛伐他汀杂质23Simvastatin Impurity 23
Simvastatin Impurity 23
CAS No.133645-46-2
Chemical FormulaC25H38O6
Purity>95%询价On request
10mg25mg50mg100mg
Simvastatin Impurity 24 structure
24
辛伐他汀杂质24Simvastatin Impurity 24
Simvastatin Impurity 24
CAS No.134523-09-4
Chemical FormulaC25H38O6
Purity>95%询价On request
10mg25mg50mg100mg
Simvastatin Impurity 26 structure
26
辛伐他汀杂质26Simvastatin Impurity 26
Simvastatin Impurity 26
CAS No.774611-54-0
Chemical FormulaC26H40O5
Purity>95%询价On request
10mg25mg50mg100mg
Simvastatin Impurity 27 structure
27
辛伐他汀杂质27Simvastatin Impurity 27
Simvastatin Impurity 27
CAS No.134970-33-5
Chemical FormulaC29H49NO5
Purity>95%询价On request
10mg25mg50mg100mg
Simvastatin Impurity 28 structure
28
辛伐他汀杂质28Simvastatin Impurity 28
Simvastatin Impurity 28
CAS No.79902-62-8
Chemical FormulaC26H38O5
Purity>95%询价On request
10mg25mg50mg100mg
Simvastatin Impurity 29 structure
29
辛伐他汀杂质29Simvastatin Impurity 29
Simvastatin Impurity 29
CAS No.198818-02-9
Chemical FormulaC25H40O7
Purity>95%询价On request
10mg25mg50mg100mg
Simvastatin Impurity 30 structure
30
辛伐他汀杂质30Simvastatin Impurity 30
Simvastatin Impurity 30
CAS No.121624-18-8
Chemical FormulaC25H36O5
Purity>95%询价On request
10mg25mg50mg100mg
Simvastatin Impurity 31 structure
31
辛伐他汀杂质31Simvastatin Impurity 31
Simvastatin Impurity 31
CAS No.114883-29-3
Chemical FormulaC25H38O6
Purity>95%询价On request
10mg25mg50mg100mg
Simvastatin Impurity 32 structure
32
辛伐他汀杂质32Simvastatin Impurity 32
Simvastatin Impurity 32
CAS No.114883-30-6
Chemical FormulaC25H36O7
Purity>95%询价On request
10mg25mg50mg100mg
Simvastatin Impurity 33 structure
33
辛伐他汀杂质33Simvastatin Impurity 33
Simvastatin Impurity 33
CAS No.2727279-69-9
Chemical FormulaC25H36O7
Purity>95%询价On request
10mg25mg50mg100mg
Simvastatin Impurity 34 structure
34
辛伐他汀杂质34Simvastatin Impurity 34
Simvastatin Impurity 34
CAS No.125206-31-7
Chemical FormulaC25H36O7
Purity>95%询价On request
10mg25mg50mg100mg
Simvastatin Impurity 35 structure
35
辛伐他汀杂质35Simvastatin Impurity 35
Simvastatin Impurity 35
CAS No.2725714-59-8
Chemical FormulaC25H36O7
Purity>95%询价On request
10mg25mg50mg100mg
Simvastatin Impurity 36 structure
36
辛伐他汀杂质36Simvastatin Impurity 36
Simvastatin Impurity 36
CAS No.134395-21-4
Chemical FormulaC25H37ClO6
Purity>95%询价On request
10mg25mg50mg100mg
Simvastatin Impurity 37 structure
37
辛伐他汀杂质37Simvastatin Impurity 37
Simvastatin Impurity 37
CAS No.134395-20-3
Chemical FormulaC31H51ClO6Si
Purity>95%询价On request
10mg25mg50mg100mg
Simvastatin Impurity 38 structure
38
辛伐他汀杂质38Simvastatin Impurity 38
Simvastatin Impurity 38
CAS No.123852-22-2
Chemical FormulaC31H52ClNO7Si
Purity>95%询价On request
10mg25mg50mg100mg
Simvastatin Impurity 39 structure
39
辛伐他汀杂质39Simvastatin Impurity 39
Simvastatin Impurity 39
CAS No.123852-10-8
Chemical FormulaC31H53ClO6Si
Purity>95%询价On request
10mg25mg50mg100mg
Simvastatin Impurity 40 structure
40
辛伐他汀杂质40Simvastatin Impurity 40
Simvastatin Impurity 40
CAS No.125142-16-7
Chemical FormulaC31H54O6Si
Purity>95%询价On request
10mg25mg50mg100mg
Simvastatin Impurity 41 structure
41
辛伐他汀杂质41Simvastatin Impurity 41
Simvastatin Impurity 41
CAS No.125175-64-6
Chemical FormulaC31H52O6Si
Purity>95%询价On request
10mg25mg50mg100mg
Simvastatin Impurity 42 structure
42
辛伐他汀杂质42Simvastatin Impurity 42
Simvastatin Impurity 42
CAS No.1094101-38-8
Chemical FormulaC37H68O6Si2
Purity>95%询价On request
10mg25mg50mg100mg
Simvastatin Impurity 43 structure
43
辛伐他汀杂质43Simvastatin Impurity 43
Simvastatin Impurity 43
CAS No.1217685-81-8
Chemical FormulaC42H70N4O6Si2
Purity>95%询价On request
10mg25mg50mg100mg
Simvastatin Impurity 44 structure
44
辛伐他汀杂质44Simvastatin Impurity 44
Simvastatin Impurity 44
CAS No.1795790-98-5
Chemical FormulaC25H36O7
Purity>95%询价On request
10mg25mg50mg100mg
Simvastatin Impurity 45 structure
45
辛伐他汀杂质45Simvastatin Impurity 45
Simvastatin Impurity 45
CAS No.79902-58-2
Chemical FormulaC32H52O5Si
Purity>95%询价On request
10mg25mg50mg100mg
Simvastatin Impurity 46 structure
46
辛伐他汀杂质46Simvastatin Impurity 46
Simvastatin Impurity 46
CAS No.477877-98-8
Chemical FormulaC26H40O5
Purity>95%询价On request
10mg25mg50mg100mg
Simvastatin Impurity 47 structure
47
辛伐他汀杂质47Simvastatin Impurity 47
Simvastatin Impurity 47
CAS No.1346601-43-1
Chemical FormulaC53H80O10
Purity>95%询价On request
10mg25mg50mg100mg
Simvastatin Impurity 48 structure
48
辛伐他汀杂质48Simvastatin Impurity 48
Simvastatin Impurity 48
CAS No.1426939-44-7
Chemical FormulaC25H36O5
Purity>95%询价On request
10mg25mg50mg100mg
Simvastatin Impurity 59 structure
59
辛伐他汀杂质59Simvastatin Impurity 59
Simvastatin Impurity 59
CAS No.58889-19-3
Chemical FormulaC18H26O4
Purity>95%询价On request
10mg25mg50mg100mg
Simvastatin Impurity 60 structure
60
辛伐他汀杂质60Simvastatin Impurity 60
Simvastatin Impurity 60
CAS No.79394-47-1
Chemical FormulaC19H28O3
Purity>95%询价On request
10mg25mg50mg100mg
Simvastatin Impurity 62 structure
62
辛伐他汀杂质62Simvastatin Impurity 62
Simvastatin Impurity 62
CAS No.163448-23-5
Chemical FormulaC31H51NO5
Purity>95%询价On request
10mg25mg50mg100mg
Simvastatin Impurity 63 structure
63
辛伐他汀杂质63Simvastatin Impurity 63
Simvastatin Impurity 63
CAS No.2681274-28-0
Chemical FormulaC25H38O5
Purity>95%询价On request
10mg25mg50mg100mg
Simvastatin Impurity 33-d6 structure
33-D6
辛伐他汀杂质33-d6Simvastatin Impurity 33-d6
Simvastatin Impurity 33-d6
CAS No.1346604-34-9
Chemical FormulaC25H30D6O7
Purity>95%询价On request
Simvastatin Impurity 35-d6 structure
35-D6
辛伐他汀杂质35-d6Simvastatin Impurity 35-d6
Simvastatin Impurity 35-d6
CAS No.1346600-14-3
Chemical FormulaC25H30D6O7
Purity>95%询价On request

结构式清晰度以随货 COA 与厂家图谱为准;目录之外的杂质可按需定制合成或调取。Structural confirmation is governed by the COA and manufacturer spectra. Impurities outside this list can be custom-synthesised or sourced on request.

Literature & synthesis

辛伐他汀 —— 研究文献与合成路线Simvastatin — literature & synthetic routes

以下题录由公开学术数据库按品种名检索汇总,供 辛伐他汀 的杂质谱研究、分析方法开发与工艺路线选择参考。文献题名与专利标题均可点击查看原文,版权归原作者与出版方所有。Citations below are aggregated from public scholarly databases by drug-substance name, for reference in impurity profiling, analytical method development and route selection for Simvastatin. Titles link to the original records; copyright remains with the authors and publishers.

杂质与降解研究文献Impurity & degradation studies

  1. Stability Indicating RP-HPLC Method for Simultaneous Determination of Simvastatin and Ezetimibe from Tablet Dosage Form
    Dixit RP, Barhate CR, Padhye SG, et al. · Indian journal of pharmaceutical sciences · 2010 · 被引 18cited 18
  2. Simvastatin modulates estrogen signaling in uterine leiomyoma via regulating receptor palmitoylation, trafficking and degradation
    Afrin S, El Sabeh M, Islam MS, et al. · Pharmacological research · 2021 · 被引 37cited 37
  3. Simvastatin and atorvastatin facilitates amyloid β-protein degradation in extracellular spaces by increasing neprilysin secretion from astrocytes through activation of MAPK/Erk1/2 pathways
    Yamamoto N, Fujii Y, Kasahara R, et al. · Glia · 2016 · 被引 57cited 57
  4. Di-(2-ethylhexyl) Phthalate Limits the Lipid-Lowering Effects of Simvastatin by Promoting Protein Degradation of Low-Density Lipoprotein Receptor: Role of PPARγ-PCSK9 and LXRα-IDOL Signaling Pathways
    Guo BC, Kuo KL, Huang JW, et al. · Antioxidants (Basel, Switzerland) · 2023 · 被引 4cited 4
  5. Simvastatin induces degradation of the extracellular matrix in human leiomyomata: novel in vitro, in vivo, and patient level evidence of matrix metalloproteinase involvement
    Britten J, Roura-Monllor JA, Malik M, et al. · F&S science · 2024 · 被引 3cited 3
  6. Synthesis, characterization and quantification of simvastatin metabolites and impurities
    Bhatia MS, Jadhav SD, Bhatia NM, et al. · Scientia pharmaceutica · 2011 · 被引 7cited 7

合成与制备工艺专利Synthesis & process patents

  1. Process for Preparing Substantially Pure Simvastatin
    CHATTERJEE SUGATA, RAWAT AJAY SINGH, KUMAR NEERAJ, RAJANIKANTH JETTI, et al. · 公开号 US2011282074US2011282074 · 2011
  2. PROCESS FOR PREPARING SIMVASTATIN
    MANDAVA VENKATA NAGA, SINGAMSETTY RADHA KRISHNA, VUJJNI SATISH KUMAR, KUMAR VADALI RAVI, et al. · 公开号 US2009048335US2009048335 · 2009
  3. PROCESS FOR MANUFACTURE OF SIMVASTATIN
    KADAM SUBHASH RAJARAM, PATIL MAHENDRA RAGHUNATH, PATIL MADHUKAR SHALIGRAM, SASANE SACHIN ARUN · 公开号 MX2007009422MX2007009422 · 2007
  4. PROCESS FOR PREPARING SIMVASTATIN AND INTERMEDIATES THEREOF
    KORODI FERENC · 公开号 KR20080034190KR20080034190 · 2008
  5. Lovastatin, simvastatin and simvastatin-6-oxide nitro-oxo-derivative and preparation method thereof
    YUYING CHEN, WENJIE REN, KUN LI · 公开号 CN101613284CN101613284 · 2009

题录与链接来自公开数据库 Europe PMC(含 PubMed 与全球专利题录)与 WIPO PatentScope,本站仅提供索引,不转载正文;如链接失效请以数据库检索为准。Citations are indexed from public databases (Europe PMC incl. PubMed and patent records, WIPO PatentScope); we provide links only and do not reproduce full text.

For formulation & analytical R&D

辛伐他汀 杂质谱研究要点Simvastatin — impurity profiling notes

下面这些是拿到 辛伐他汀 的 54 个杂质条目之后,仿制药研发最常遇到的几件事。先把杂质的来源分清,再决定要不要买对照品、买哪几个。Once you have the 54 impurity entries for Simvastatin, these are the questions that come up most in generic development. Classify the source of each impurity first, then decide which reference standards you actually need.

01工艺杂质Process impurities

起始物料、中间体、副产物、催化剂与溶剂残留。多来自合成路线本身,应在工艺开发阶段用加标试验定位。Starting materials, intermediates, by-products, catalysts and residual solvents — traced back to the synthetic route and located with spiking studies during process development.

02降解杂质Degradation impurities

水解、氧化、光解、高温高湿与聚合产物。需通过强制降解试验识别,并确认方法具备稳定性指示能力。Hydrolytic, oxidative, photolytic, thermal and polymeric degradants — identified through forced degradation, with the method proven stability-indicating.

03药典杂质Pharmacopoeial impurities

EP/USP 已收载并有官方编号的杂质(如 EP Impurity A、USP Related Compound B)。申报时通常需逐项对照。Impurities already monographed with official designations (e.g. EP Impurity A, USP Related Compound B), normally compared item by item during filing.

04基因毒性杂质Genotoxic impurities

含警示结构、需按 ICH M7 进行危害评估与限度推导(TTC 1.5 µg/日)。该类杂质必须用对照品准确控制。Structurally alerting compounds requiring ICH M7 hazard assessment and limit derivation (TTC 1.5 µg/day); these must be controlled with an authentic reference standard.

05同位素标记物Isotopically labelled standards

氘代、¹³C、¹⁵N 标记的同类物,主要用作 LC-MS/MS 生物分析的内标,抵消基质效应与回收率波动。Deuterated, ¹³C- and ¹⁵N-labelled analogues used as internal standards in LC-MS/MS bioanalysis to compensate matrix effects and recovery variation.

06代谢与转化产物Metabolites & conversion products

体内代谢物、强制降解转化物与工艺中间态,常见于杂质谱比对与稳定性考察中。In-vivo metabolites, forced-degradation products and process intermediates encountered in impurity profiling and stability studies.

本品种含药典编号杂质(EP/USP)。申报时药典已收载的杂质通常需要逐项对照,建议优先备齐药典编号对照品,再补充工艺与降解杂质。This drug substance includes pharmacopoeially designated impurities (EP/USP). Monographed impurities normally need item-by-item comparison during filing, so secure the pharmacopoeial standards first, then fill in process and degradation impurities.

方法开发与对照品使用建议Method development and standards usage

先定分离,再谈定量Resolution first, then quantification

主成分与相邻杂质峰分离度应 ≥1.5;用杂质对照品确定相对保留时间与相对响应因子,避免用自身对照法掩盖响应差异。Target baseline resolution ≥1.5 between the main component and adjacent impurities; establish relative retention and relative response factors with authentic impurity standards rather than relying on self-comparison.

校正因子不可忽略Never ignore response factors

紫外吸收差异大的杂质必须校正,否则定量结果系统性偏低或偏高。EP/USP 已给出校正因子的按药典执行。Impurities with markedly different UV response need correction, otherwise results are systematically biased. Where EP/USP publish a correction factor, follow the monograph.

强制降解要做全Run the full forced-degradation panel

建议覆盖酸、碱、氧化(H₂O₂)、光照(ICH Q1B)、高温高湿;主峰纯度用二极管阵列或质谱确认。Cover acid, base, peroxide oxidation, photostability (ICH Q1B) and heat/humidity; confirm peak purity by DAD or MS.

定义报告阈值Set reporting and identification thresholds

按 ICH Q3A/Q3B 设定报告阈值、鉴定阈值与界定阈值,避免为无意义的峰投入过多工作量。Apply ICH Q3A/Q3B reporting, identification and qualification thresholds so effort is not spent on insignificant peaks.

标准品储存有讲究Store standards properly

杂质对照品多建议 −20 ℃ 避光、干燥、密封保存;溶液现配现用,并记录开瓶与配制日期。Most impurity standards should be stored at −20 °C, protected from light and moisture; prepare solutions fresh and record opening and preparation dates.

用结构式先做初判Start from the structure

先比对杂质与主成分的结构差异,可预判其保留行为、紫外响应与可能的降解路径,能显著减少试错。Comparing the impurity structure with the parent drug predicts retention behaviour, UV response and probable degradation routes, cutting trial and error.

以上为通行的杂质研究实践提示,不针对具体品种给出结论。实际限度、校正因子与色谱条件请以 EP/USP 各论及你们的验证数据为准。需要某个杂质的结构确证资料、COA 或定制合成,可直接联系我们。The above are general impurity-profiling notes and are not conclusions about this specific drug substance. Actual limits, correction factors and chromatographic conditions follow the EP/USP monograph and your own validation data. Contact us for structural confirmation data, COAs or custom synthesis.
索取杂质谱报价 / COARequest a quote / COA← 查看其它品种← Other drug substances